In conclusion, in contrast to FABP4, circulating FABP5 is independently associated with both decreased CEC and carotid atherosclerosis, suggesting that FABP5 level is a regulatory factor of CEC and a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages. This evidence concerns the gene FABP4 and carotid atherosclerosis.